[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100598492":3},{"organization":4,"armGroups":7,"interventions":27,"overallOfficials":11,"centralContacts":45,"locations":51,"responsibleParty":115,"collaborators":11,"id":117,"slug":118,"hasResults":119,"nctId":120,"briefTitle":121,"officialTitle":122,"acronym":11,"eligibilityCriteria":123,"healthyVolunteers":119,"sex":124,"minAge":125,"maxAge":11,"enrollmentInfo":126,"targetDuration":11,"studyType":129,"phases":130,"briefSummary":132,"conditions":133,"keywords":136,"overallStatus":54,"whyStopped":11,"lastUpdateSubmitDate":138,"lastUpdatePostDateStruct":139,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":147},{"fullName":5,"class":6},"Animuscure Inc.","INDUSTRY",[8,14,18,22],{"label":9,"type":10,"description":11,"interventionNames":12},"AMC6156 0.1mg Treatment Group","EXPERIMENTAL",null,[13],"Drug: AMC6156 0.1mg",{"label":15,"type":10,"description":11,"interventionNames":16},"AMC6156 0.3mg Treatment Group",[17],"Drug: AMC6156 0.3mg",{"label":19,"type":10,"description":11,"interventionNames":20},"AMC6156 1.0mg Treatment Group",[21],"Drug: AMC6156 1.0mg",{"label":23,"type":24,"description":11,"interventionNames":25},"Placebo Control Group","PLACEBO_COMPARATOR",[26],"Drug: Placebo",[28,33,37,41],{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":11},"DRUG","AMC6156 0.1mg","Oral administration of AMC6156 in tablet form at a dose of 0.1 mg once daily for 12 weeks.",[9],{"type":29,"name":34,"description":35,"armGroupLabels":36,"otherNames":11},"AMC6156 0.3mg","Oral administration of AMC6156 in tablet form at a dose of 0.3 mg once daily for 12 weeks.",[15],{"type":29,"name":38,"description":39,"armGroupLabels":40,"otherNames":11},"AMC6156 1.0mg","Oral administration of AMC6156 in tablet form at a dose of 1.0 mg once daily for 12 weeks.",[19],{"type":29,"name":42,"description":43,"armGroupLabels":44,"otherNames":11},"Placebo","Oral administration of placebo tablets matching AMC6156 in appearance, once daily for 12 weeks.",[23],[46],{"name":47,"role":48,"phone":49,"phoneExt":11,"email":50},"Jooyeon Kim","CONTACT","+82-70-4105-6414","yeoooonee@animuscure.com",[52,72,85,100],{"facility":53,"status":54,"city":55,"state":56,"zip":57,"country":58,"countryCode":11,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"CHA Bundang Medical Center","RECRUITING","Seongnam-si","Gyeonggi-do","13496","South Korea",{"type":60,"coordinates":61},"Point",[62,63],127.13778,37.43861,{"lat":63,"lon":62},[66,70],{"name":67,"role":48,"phone":68,"phoneExt":11,"email":69},"Kyounghoon Min, M.D.","+82-10-8973-3732","minkhrm@gmail.com",{"name":67,"role":71,"phone":11,"phoneExt":11,"email":11},"PRINCIPAL_INVESTIGATOR",{"facility":73,"status":74,"city":55,"state":56,"zip":75,"country":58,"countryCode":11,"cosmosGeoPoint":76,"geoPoint":78,"contacts":79},"Seoul National University Bundang Hospital","NOT_YET_RECRUITING","13620",{"type":60,"coordinates":77},[62,63],{"lat":63,"lon":62},[80,84],{"name":81,"role":48,"phone":82,"phoneExt":11,"email":83},"Jaeyoung Lim, M.D.","+82-10-5390-0373","drlim1@snu.ac.kr",{"name":81,"role":71,"phone":11,"phoneExt":11,"email":11},{"facility":86,"status":54,"city":87,"state":56,"zip":88,"country":58,"countryCode":11,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Ajou University Hospital","Suwon","16499",{"type":60,"coordinates":90},[91,92],127.00889,37.29111,{"lat":92,"lon":91},[95,99],{"name":96,"role":48,"phone":97,"phoneExt":11,"email":98},"Yoonseok Jung, M.D.","+82-10-7107-6789","yschung@ajou.ac.kr",{"name":96,"role":71,"phone":11,"phoneExt":11,"email":11},{"facility":101,"status":54,"city":102,"state":102,"zip":103,"country":58,"countryCode":11,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Seoul National University Hospital","Seoul","03080",{"type":60,"coordinates":105},[106,107],126.9784,37.566,{"lat":107,"lon":106},[110,114],{"name":111,"role":48,"phone":112,"phoneExt":11,"email":113},"Sangyoon Lee, M.D.","+82-10-6351-4751","rehabilee@gmail.com",{"name":111,"role":71,"phone":11,"phoneExt":11,"email":11},{"type":116,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100598492","phase-2-a-study-of-amc6156-in-people-with-sarcopenia-100598492",false,"NCT07072195","A Study of AMC6156 in People With Sarcopenia","A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of AMC6156 in Patients With Sarcopenia","Inclusion Criteria:\n\n* Voluntary participation with written informed consent\n* Male ≥ 65 years or postmenopausal female\n* Diagnosed with sarcopenia:\n* ASM \\\u003C 7.0 kg\u002Fm² (men) or \\\u003C 5.4 kg\u002Fm² (women)\n* Plus low handgrip strength or SPPB ≤ 9\n* MNA screening score ≥ 8\n* Body weight ≥ 35 kg, BMI between 15-30 kg\u002Fm²\n* Willing and able to follow exercise and nutrition guidance\n\nExclusion Criteria:\n\n* Allergy to investigational drug\n* History of GI bleeding, ulcers, or severe liver\u002Fkidney\u002Fheart disease\n* QTc ≥ 450 ms with symptoms\n* Severe COPD, uncontrolled diabetes or thyroid disease\n* Diseases causing cachexia or muscle wasting (e.g., ALS, Parkinson's)\n* Vitamin D deficiency (\\\u003C10 ng\u002FmL), hemoglobin \\\u003C10 g\u002FdL\n* Severe psychiatric disorders or MMSE \\\u003C 21\n* Inability to walk or recent fracture\u002Fsurgery affecting mobility\n* Use of prohibited medications or recent participation in other clinical trials\n* Investigator deems the subject unsuitable for the study","ALL","65 Years",{"count":127,"type":128},80,"ESTIMATED","INTERVENTIONAL",[131],"PHASE2","This clinical trial aims to find out whether AMC6156 can improve physical function and is safe in older adults with sarcopenia. Participants will take AMC6156 or a placebo daily for 12 weeks, and their movement, strength, and safety will be regularly monitored through tests and checkups.",[134,135],"Sarcopenia in Elderly","Sarcopenia",[137],"sarcopenia","2025-07-24",{"date":140,"type":141},"2025-07-29","ACTUAL",{"date":143,"type":141},"2025-07-01",{"date":145,"type":128},"2026-06",{"name":5,"class":6},4]